Displaying items by tag: James Hardie

New Zealand: Victims of leaky homes are being urged to join a class action being formed against James Hardie over one of its fibre cement cladding products, HardieTex.

Law firm Parker & Associates has filed a High Court case on behalf of a Wellington couple, who have claimed that HardieTex was the cause of their US$200,000 leaky home problem. The claim alleges that James Hardie was negligent in the design, manufacture and supply of HardieTex, which was used to build thousands of houses through the 1990s and early 2000s. Building owners who have suffered damage have until December 2015 to join the action.

The country manager for James Hardie in New Zealand, Justin Burgess, said that HardieTex is no longer on the market.

Australia: James Hardie Industries has 'washed its hands' of any responsibility for a shortfall in compensation payments to asbestos victims as it reported robust profit growth and rewarded shareholders with an ordinary second half dividend of US$120m and a US$98m special dividend.

In February 2015, Andrew Constance, who was then New South Wales treasurer, agreed to increase the state's loan facility to the Asbestos Injuries Compensation Fund (AICF) by more than US$100m after a blowout in expensive mesothelioma claims threatened to leave the fund short of cash for future claims. Constance amended the loan terms after the fund said in 2014 that contributions from James Hardie were likely to be insufficient and it would apply to the NSW courts to pay some claimants in instalments unless it received a top-up. Under the terms of an agreement struck in 2007, James Hardie pays 35% of its operating cashflow to the fund.

Group chief financial officer Matt Marsh said that dividend policy was unrelated to asbestos liabilities. "The way we declare our dividends isn't related to the AICF," said Marsh. "We always prioritise making that payment to the AICF and then we start to allocate our capital that is left over." During 2014 - 2015, James Hardie paid US$113m to the AICF. It expects to make another payment of US$62.8m on 1 July 2015. James Hardie has paid US$718m to the fund since it was set up in 2007.

Chief executive Louis Gries said that James Hardie's manufacturing plants, 'Were getting a pretty good kick' in the quarter that ended on 31 March 2015 following some start-up troubles earlier in the year, while falling pulp and freight prices had reduced costs. During the quarter, earnings before interest and tax margins hit the top end of the group's 20 – 25% range. He said that after focus on operational improvements over the past two years, the company would now chase sales. "We are definitely shifting more of our management attention to how we grow the top line rather than how we get efficiencies," said Gries.

James Hardie is aiming for fibre cement to account for 35% of the external cladding used in the US housing market, with James Hardie controlling 90% of that market. During the 2014 - 2015 year, the company spent US$173m on expansion projects to meet growing demand. Gries said that James Hardie's plants and capacity would keep expanding along with the housing recovery. James Hardie expects US housing starts of 1.1 - 1.2m in 2015 - 2016 and 'improved results' in the Asia Pacific region.

US/Australia: James Hardie chief executive Louis Gries said that the pace of the US housing recovery is underwhelming and remains below expectations as he reported an 11% rise in its third quarter 2015 adjusted profit to US$48.6m. Gries said that James Hardie has managed to increase prices on some product lines despite the slower-than-expected rebound in new home building in the world's biggest economy.

"We have higher volumes in all of our businesses and our average price is up in the US. The US housing market is still pretty flat for new construction. Housing starts are well below what you'd expect three to four years into a recovery," said Gries.
Despite on-going muted building in the US, where James Hardie derives about 80% per cent of its revenue, the company is going ahead with big capacity expansions at its Plant City, Florida, plant and at plants in Cleburne, Texas and Carole Park in Queensland, Australia. In the first nine months of its 2015 financial year, which ended on 31 December 2014, James Hardie spent US$154.3m on capacity expansions and new land acquisitions in New South Wales, Australia and Tacoma, Washington, USA. Some capacity expansions have been delayed pending a pick up in conditions.

James Hardie's net operating profit in the quarter that ended on 31 December 2014 rose by 17% year-on-year to US$108m. Revenue rose by 10% to US$388m. James Hardie expects full-year adjusted net operating profit to be between US$210 - 222m. In its Asia Pacific business, James Hardie expects strong growth in the Philippines due to momentum in high rise developments and a push into the commercial building market. The Australian and New Zealand businesses are both expected to improve on the back of strong new home building and a rebound in repairs and remodelling in Australia.

James Hardie has a legacy asbestos liability to compensate victims suffering asebestos-related diseases from use of the company's former products. It pays 35% of its operating cash flow into the independently-run Asbestos Injuries Compensation Fund (AICF). In the first nine months of its financial year, asbestos claims were 11% higher than actuarial expectations. On 1 July 2014, James Hardie paid US$113m to the AICF.

Australia: Fibre cement producer James Hardie has posted a sharp increase in its operating profit for the second quarter of its 2015 financial year, despite a slower-than-expected recovery in the US housing sector.

James Hardie, which generates 66% of its revenue in Europe and the US, had warned of short-term US uncertainty with the recent 'flattening in housing activity,' but has forecast a moderate improvement for the year ending in March 2015. Its Australian, New Zealand and Philippines businesses are also expected to improve.

"Management cautions that, although US housing activity has been improving for some time, market conditions remain somewhat uncertain and some input costs remain volatile," said James Hardie.

The company reported a net operating profit of US$127m for the quarter that ended 30 September 2014, up from US$51.9m in the same period of 2013. Chief executive Louis Gries said that the 66% jump reflected increased volumes and higher average net sales prices across its US, European and Asian fibre cement businesses, which drove net sales up by 12% for both the quarter and the half-year. "The recovery of the US housing market remains below our expectations at the beginning of the year," said Gries.

For the 2015 financial year, James Hardie expects US$205 – 235m of net operating profit, excluding asbestos compensation costs. In the 2014 financial year, the company reported US$197m of net operating profit.

Australia: James Hardie Industries, an Australian fibre cement producer, has posted an 80% fall in its net profit to US$28.9m during the first quarter of its 2015 fiscal year, which ended on 30 June 2014. During the same period of its 2014 fiscal year, net profit was US$142m.

The company revised down its full year earnings expectations due to an uncertain US economic recovery. James Hardie generates 66% of its revenue in Europe and the USA. James Hardie's CEO, Louis Gries, said that the US market 'is recovering more modestly than we assumed at the start of the year.'

Australia: Fibre cement producer James Hardie Industries said on 22 May 2014 that it expects the US housing construction market to improve in 2014 as it posted a more than doubling in annual net profit. "The company continues to expect improvement in the US operating environment," said James Hardie.

James Hardie, which generates two-thirds of its revenue in Europe and the US, said that its annual net sales in those markets grew by 19%, helped by strong rises in US single-family building permits. James Hardie posted a net profit of US$99.5m for the year to 31 March 2014, up from US$45.5m in the previous year. Net operating profit, which excludes charges for asbestos liability, asset impairments and regulatory charges, was US$197.2m compared with US$140.8m in the prior year. Overall net sales grew by 13% to US$1.49bn.

James Hardie has been compensating Australian victims of asbestos-related illnesses such as mesothelioma and said that its asbestos liability grew by US$186.18m to US$1.44bn by 31 March 2014, after the number of claims were higher than expected for a second consecutive year.